[{"address1": "910 Clopper Road", "address2": "Suite 201S", "city": "Gaithersburg", "state": "MD", "zip": "20878", "country": "United States", "phone": "240 654 1450", "website": "https://altimmune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity, metabolic, and liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 trial for the treatment of obesity and metabolic associated steatohepatitis. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Dr. Vipin K. Garg Ph.D.", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 992999, "exercisedValue": 0, "unexercisedValue": 1959778}, {"maxAge": 1, "name": "Dr. M. Scot Roberts Ph.D.", "age": 65, "title": "Chief Scientific Officer", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 648960, "exercisedValue": 0, "unexercisedValue": 290514}, {"maxAge": 1, "name": "Mr. Gregory L. Weaver CPA, M.B.A.", "age": 68, "title": "Chief Financial Officer", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Shutterly M.S.", "age": 36, "title": "Principal Financial & Accounting Officer and Corporate Controller", "yearBorn": 1988, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bertrand  Georges Ph.D.", "title": "Chief Technology Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Blandin B.S.", "title": "Vice President of Quality & Compliance Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Robin E. Abrams J.D.", "age": 60, "title": "General Counsel", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Raymond M. Jordt M.B.A.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 578850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Linda M. Richardson", "age": 60, "title": "Chief Commercial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christophe  Arbet-Engels M.B.A., M.D., Ph.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 6, "governanceEpochDate": 1759276800, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.07, "open": 4.25, "dayLow": 3.99, "dayHigh": 4.25, "regularMarketPreviousClose": 4.07, "regularMarketOpen": 4.25, "regularMarketDayLow": 3.99, "regularMarketDayHigh": 4.25, "exDividendDate": 1484870400, "payoutRatio": 0.0, "beta": 0.063, "forwardPE": -2.7551022, "volume": 2430762, "regularMarketVolume": 2430762, "averageVolume": 2749857, "averageVolume10days": 2531540, "averageDailyVolume10Day": 2531540, "bid": 4.01, "ask": 4.09, "bidSize": 4, "askSize": 4, "marketCap": 358324448, "fiftyTwoWeekLow": 2.9, "fiftyTwoWeekHigh": 11.16, "allTimeHigh": 137.7, "allTimeLow": 1.51, "priceToSalesTrailing12Months": 17916.223, "fiftyDayAverage": 3.8358, "twoHundredDayAverage": 4.95605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 190185872, "profitMargins": 0.0, "floatShares": 87577672, "sharesOutstanding": 88257253, "sharesShort": 21503786, "sharesShortPriorMonth": 25084923, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.24360001, "heldPercentInsiders": 0.0077899997, "heldPercentInstitutions": 0.42664, "shortRatio": 7.26, "shortPercentOfFloat": 0.24540001, "impliedSharesOutstanding": 88475172, "bookValue": 1.897, "priceToBook": 2.1349502, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -87746000, "trailingEps": -1.18, "forwardEps": -1.47, "lastSplitFactor": "1:30", "lastSplitDate": 1536883200, "enterpriseToRevenue": 9509.294, "enterpriseToEbitda": -2.018, "52WeekChange": -0.4035346, "SandP52WeekChange": 0.19736934, "quoteType": "EQUITY", "currentPrice": 4.05, "targetHighPrice": 28.0, "targetLowPrice": 1.0, "targetMeanPrice": 16.44444, "targetMedianPrice": 18.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 183104992, "totalCashPerShare": 2.075, "ebitda": -94241000, "totalDebt": 15849000, "quickRatio": 19.955, "currentRatio": 20.436, "totalRevenue": 20000, "debtToEquity": 9.822, "revenuePerShare": 0.0, "returnOnAssets": -0.32434, "returnOnEquity": -0.55907, "grossProfits": -72627000, "freeCashflow": -49829248, "operatingCashflow": -81573000, "revenueGrowth": 0.0, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -4584.4, "financialCurrency": "USD", "symbol": "ALT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketPrice": 4.05, "shortName": "Altimmune, Inc.", "longName": "Altimmune, Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1761955179, "regularMarketTime": 1761940801, "exchange": "NGM", "messageBoardId": "finmb_4866807", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1495805400000, "regularMarketChangePercent": -0.4914, "averageDailyVolume3Month": 2749857, "fiftyTwoWeekLowChange": 1.1500001, "fiftyTwoWeekLowChangePercent": 0.39655176, "fiftyTwoWeekRange": "2.9 - 11.16", "fiftyTwoWeekHighChange": -7.1099997, "fiftyTwoWeekHighChangePercent": -0.63709676, "fiftyTwoWeekChangePercent": -40.35346, "dividendDate": 1536883200, "earningsTimestamp": 1762432200, "earningsTimestampStart": 1762432200, "earningsTimestampEnd": 1762432200, "earningsCallTimestampStart": 1762435800, "earningsCallTimestampEnd": 1762435800, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.18, "epsForward": -1.47, "epsCurrentYear": -1.13125, "priceEpsCurrentYear": -3.5801105, "fiftyDayAverageChange": 0.21420026, "fiftyDayAverageChangePercent": 0.055842396, "twoHundredDayAverageChange": -0.9060497, "twoHundredDayAverageChangePercent": -0.18281691, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "cryptoTradeable": false, "postMarketChangePercent": -0.24444672, "postMarketPrice": 4.0401, "postMarketChange": -0.009900093, "regularMarketChange": -0.02, "regularMarketDayRange": "3.99 - 4.25", "fullExchangeName": "NasdaqGM", "displayName": "Altimmune", "trailingPegRatio": null, "__fetch_time": "2025-11-01"}]